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THE DIAGNOSIS AND TREATMENT
OF TUMORS OF THE BREAST*
SAMUEL C. HARVEY
The subject of tumors of the breast, and particularly the differ-
ential diagnosis of these, seems one adequately considered in all texts
of surgery and in many monographs; indeed, it is a question to
which every medical student is expected to know the answer. Yet
I know ofno problem in the clinic that is today more worrisome, that
requires a better balanced judgment, or for which the solution is
more often based upon intangible evidence.
This may not have been true to the same degree in the past when
carcinoma of the breast for the most part was seen in the late stages
of the disease, presenting the typical text-book picture, and when
no woman worried about a "lump" in her breast until it was the size
of an orange or had ulcerated, or gave her excruciating pain.
Today, this situation has changed with the education of the
public and of the family physician, who have learned that the small-
est detectable change from normal in the breast may spell disaster
and should be seen by the surgeon at once. Minor discomfort, a
drop of secretion, a little excoriation, or a nodule so small that the
examiner may be humiliated by being forced to ask the patient to
find it for him, are of common occurrence. That this is true is
shown in the rising rate of apparent arrests by treatment of carcinoma
of the breast, for the lesion is seen more and more frequently at
an early stage when radical mastectomy may be done with a con-
siderable chance of benefit. In our own experience8, with no change
in treatment-radical surgery-and without radiation of any type,
the three-year survivals have risen from 43.5 per cent in the years
1921 to 1925 inclusive to 71.5 per cent in the years 1926 to 1930
inclusive, and the five-year survivals from 31 per cent in the first
period to 66 per cent in the second. While this shift may be
peculiar to this clinic, I suspect that a similar change accounts for
some of the statistics supposed to illustrate the benefits of pre-
operative and postoperative radiation. Bloodgood2 has more direct
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evidence as to the frequent appearance of the early lesion, for in
an experience in which three decades ago he saw less than 20 per cent
of instances in which the lesion was benign, he now sees the situation
practically reversed in that only approximately 20 per cent of
patients coming to him with a complaint concerning the breast have
malignant tumors. While this makes the outlook for the patient
much better, it renders the difficulty of diagnosis and the responsibil-
ity of the surgeon much greater.
The majority of these patients, not having carcinoma of the
breast, are suffering from some variety of that puzzling and ill-
defined disease of the breast, which has received about as many
names as it has had investigators, that is, " chronic cystic mastitis" as
it is most commonly called in American literature. It is this condi-
tion, which must be differentiated from cancer of the breast, that is
to be discussed.
In order better to understand the present situation, it is best to
review the development of our knowledge from the historical view-
point. This disease was first clearly described and differentiated
from malignant disease of the breast by Sir Astley Cooper' in his
splendid monograph on "The Anatomy and Diseases of the Breast"
published in Philadelphia in 1845. This is admirably illustrated
with plates showing fibroadenomata and cysts of, the breast, all of
which he included under "Hydatid Disease of the Breast." The
term had no reference, of course, to the disease which is called
hydatid today. From the clinical experience of Velpeau30, Brodie4,
Paget2", and Gross12 came confirmation of the benignity of these
tumors, although none of these pioneers had adequate facility for
microscopic study.
With the development ofproper technic for thecutting and stain-
ing of tissue, a new period of study occurred. Brissaud5 (1883)
gave the first detailed histological description of the disease and
influenced Reclus22 in the same year to publish the first modern
description. Unfortunately, influenced as have been so many since
by the microscopic appearance, they held that the lesion was a malig-
nant one, an opinion that with further clinical experience, however,
was revised five years later. They referred to it as "La Maladie
Kystique des Mamelles," but it has since become known in the
French literature by the eponym of "Maladie de Reclus."
In the German, attention was called to the subject by Schimmel-
busch25 (1892) under the title of "Das Cystadenom der Mamma."
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He laid down three clinical characteristics which still remain cardinal
facts. (1) The disease involves the entire breast in a diffuse en-
largement with cysts varying in size from a pea to a bean,-rarely
larger. (2) There is no adhesion of the breast to adjacent structures
or to the overlying skin. (3) Both breasts are involved at the same
time or in brief sequence. Out of the 43 cases with histological
verification reported up to that time, of which Reclus had had 30 and
the author 7, only 3 had developed cancer. In the German litera-
ture, this condition is often referred to as SchimmXelbusch's disease
with a tendency to limit the eponym to "cystadenomatosis." A year
later Kdnig18 (1893) discussed the same disease under the name of
"Mastitis Chronica Cystica," being of the opinion that the process
was inflammatory in nature, and he carried with him so great an
influence that until the present the name persists with a similar
implication. Later Bloodgood' (1904) saw a striking resemblance
ofthis condition to the changes rather typical of the senile breast, and
named it "Senile Parenchymatous Hypertrophy"; a year later
Warren31 (1905), reasoning from the same basis, suggested the name
of "Abnormal Involution of the Mammary Gland."
Since then there has been a salting out of opinion as regards the
type of reaction into three general schools of thought,-the inflam-
matory, the neoplastic, and the abnormal involution: The first of
these has been largely discarded, partly because the cellular reaction
in the stroma first interpreted by K'onig'8 as characteristic of an
inflammatory process has, with more accurate cytological knowledge,
come to be recognized as not so, and partly because investigators
such as Keynes"7 have been uniformly unsuccessful in attempting to
demonstrate an infective agent. The neoplastic school, represented
today most forcibly by Cheatle7 in surgery, and by manypathologists,
is convinced by the histology of that phase of the disease in which
the ducts are filled with hyperplastic epithelium and papillomata,
that this represents a neoplastic reaction which must lead on to
cancer with a fair degree of frequency. In fact, it is diagnosed as
cancer in many instances by those of limited experience and possess-
ing a viewpoint confined to the eyepiece of the microscope. Inas-
much as it is acknowledged that the more fibrous and cystic lesions
are benign, proponents of this hypothesis are forced into considering
"chronic cystic mastitis" as being two diseases, or the whole process
at least "precancerous" and therefore neoplastic.
The third school, that holding to the theory of involution, has
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expanded, with the development of knowledge concerning the func-
tional changes in the breast, into a physiological concept of the dis-
ease based upon the response of the organ to hormonal stimulation.
This is the most striking recent development and must be considered
more in detail.
The functional part of the breast is composed of two main com-
ponents; the ducts and acini lined by epithelium and the periductal
and periacinar fibrous tissue, the "Mantelgewebe" as the Germans
say. There are then these two types oftissue which are functionally
symbiotic and of equal importance.
The growth of the breast pauses shortly after birth, but in the
female is taken up again as puberty approaches, probably under the
influence ofthe ovarian follicles which undergo stimulation from.the
hormones of the anterior lobe of the hypophysis. Anatomically this
growth consists of increase in both the fibrous tissue and the ducts
but not in the formation of acini. Overstimulation of this type, as
pointed out by Geschickter11, probably leads in the male to gyneco-
mastia, in the female to virginal hypertrophy and, where only cer-
tain areas of the breast react, to fibroadenomata. There is then a
definite hormonal stimulation of the breast in the female leading to
simple growth.
With the rupture of the follicle and the formation of the corpus
luteum, the menstrual cycle starts, to be repeated in monthly
rhythm until the climacteric or pregnancy supervenes. Exactly
what hormones are concerned in this cycle is not yet clear, although
Evans"0 lays down certain basic statements. These are to the effect
that the estrogenic substance provides for the growth of the breast
including the duct system, but not for the development of the
secretory acini. The latter, which comprise the functional develop-
ment of the gland, are dependent upon the lactogenic hormone of
the anterior lobe of the pituitary, "prolactin." The estrogenic sub-
stance is inhibitory to the "prolactin," and the two are thus in bal-
ance, while the secretion of the corpus luteum, "progestin," has no
relationship to mammary physiology.
In anycase, the anatomical changes in the breast occurring during
the estrus cycle are fairly well known. They are based on observa-
tions in both man and animals. In 1916 Loeb and Hesselberg'9,
working with the guinea pig, found that the mammary glands at the
time of heat were actively proliferating with large ducts, some of
which were even "cystically dilated" or contained "papilla-like pro-
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trusions." The epithelium was actively growing with mitoses,
changes in shape, and with vesicular nuclei. The stroma was edema-
tous and contained more lymphocytes and polymorphonuclear leuko-
cytes than were found in the resting stage.
In the rat, Sutter27 observed sprout'ing and branching of the duct
system during estrus with regression near the next proestrus stage.
Similar observations were made in the heifer by Hammond'3, and in
the opossum by Hartman"5. In addition, many investigators have
observed the experimental activation ofthe mammary glandby estro-
genic substances (Turner28, Wieser32, and Turner and Frank29).
Unfortunately, for the primates there have as yet been published
no correspondingly accurate observations. In man the information
comes from two methods of attack, one the correlation of the estrus
cycle as determined by study of the ovary and the breast, the other
by the determination of the estrus by questioning the patient and by
the study of breast tissue removed at operation. In the first instance
the study is necessarily limited to necropsy material. Such were the
initial investigations of Rosenburg24, who demonstrated that the
breasts during menstruation underwent marked proliferation of the
ductal epithelium and an increase in the cellular content of the peri-
ductal fibrous tissue. These observations were confirmed and ampli-
fied by Berberich and Jaffe. The second approach has been carried
out notably by Moszkowicz20, who was able to correlate in a striking
fashion changes in the breast removed at operation with the men-
strual cycle. Ingleby"6, in this country, has made similar studies,
and there can be no doubt that in the breast of man, as in the lower
animals, a rhythmic change in the breast analogous to that in the
endometrium takes place in conjunction with and caused by the
estrus cycle. On the basis of Ingleby's work Rodman 3 has given a
very adequate description of what takes place.
Somewhere between the menstrual cycles the breast is in its resting stage,
probably from the fifth to the fifteenth day after the last menses. At this
time the fibrous stroma predominates, the epithelial elements are only ducts
and occasional acini. In old women and obese young women fat is also
present. The ducts are lined by two layers of cells; an inner layer of
cuboidal or columnar with nuclei that are small and stain deeply; and the
basal cells that are smaller, and tend to be flattened. As the next menstrual
period approaches, the cells become larger until they divide and new ductules
are formed branching out from the old ducts like twigs on a tree. The
epithelial border around the lumen becomes somewhat jagged and irregular,
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a change similar to that seen in the glands of the premenstrual endometrium.
Meanwhile the surrounding fibrous tissue also softens, undergoing myxoma-
tous and hyaline degeneration so as to allow for the expansion of the ducts.
Lobules are thus formed which do not appear in the resting breast. The
lining epithelial cells swell, the protoplasm becomes vacuolated and the nucleus
is rounder and paler. Similar changes take place in the cells of the basal
layer. Secretion takes place into the ducts and, clinically, in many women
the breasts become swollen and tender at this stage. This then, is the pre-
menstrual phase, and about a day or two before the onset of the menstrual
flow, involution begins. At this time the epithelium degenerates and is shed
into the lumen of the ducts much the same as the superficial layers of the
endometrium are cast off during menstruation. Under the microscope, it is
seen that the architecture of the lobules has been lost, and they have a curi-
ously jumbled appearance. One now sees degenerate epithelial cells, often
varying in size and shape, intermingled with round cells and proliferating
fibrous tissue. After the menses are over these degenerated epithelial cells
are absorbed. The breast is now in the postmenstrual phase which is short, as
in about five days after the menses the breast again enters the resting stage.
Granted, then, that such a cycle occurs, one may well ask what
relationship this has to the disease "chronic cystic mastitis." The
final proofrests, of course, uponthe reproduction of the phenomenon
experimentally, and unfortunately this has not yet been convincingly
successful. To obtain the proper hormonal balance and the correct
timing is a difficult matter, but the attempts of Geschickter are at
least suggestive"1. Certain facts provide, in lieu of this, ancillary
evidence. It is not a disease peculiar to man, for it has been described
in at least one animal, the mouse (Wieser32). More important is
the frequency of occurrence, for if it is present in some degree in a
high proportion of females, then it becomes an extraordinarily prev-
alent disease or, morelikely, a verycommonphysiological aberration.
On this there are considerable data. Keynes"7, in the Hunterian
Lecture on "chronic mastitis," found in necropsy material involving
116 specimens, 59 showing "inflammatory" lesions. Before the
menopause the incidence rose to 60 per cent, so that the phenomenon
could not be explained on the basis of involution occurring at or after
the menopause. Borchardt and Jaffe3, in a similar study upon
women over 40, found some degree of this condition in 93 per cent,
and in 70 per cent it was present in both breasts. One may safely
conclude that changes of this nature are present so commonly in the
female breast that they must represent an aberration of the prolifera-
tion and regression that occur at the time of the estrus.
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The question is properly raised, however, as to the unity of this
disease. May there not be, as Cheatle and Cutler7 suggest, aphysio-
logical aberration-"mazoplasia"--and a neoplastic disease-"a des-
quamative epithelial hyperplasia"-shading into cystadenoma and
carcinoma. As a matter of fact, the drawing of a sharp line between
these two supposed entities is impossible either histologically or
dinically, for the two blend into and over each other in such a
fashion that one must consider the picture as that of one entity.
On the other hand, if one looks at the picture as a whole, there
is a sharp line of demarcation between carcinoma and "cystic mas-
titis." In the former the natural history of the disease is that of
malignancy, in the latter of benignity. It is true, if one studies
the histology ofthe benign lesion, particularly during the most active
phase of physiological hyperplasia, that a picture is often presented
in which the impression is gained that the epithelium is about to
plunge through the barrier of the membrana propria and establish
an invasive focus of cancer. The histologist is loath to take the
responsibility of calling such a picture benign; unfortunately, an
equivocal answer may be found in terming it "precancerous," in
which case he is always right whatever the later course of the disease
may disclose. As a matter of fact, as Bloodgood2 has pointed out
from a long experience, when the proliferating epithelium is not
unquestionably and readily seen to be invasive, the lesion is benign.
In other words, real malignancy does not simulate benign disease,
whereas many forms of benign disease may suggest histologically
the malignant. A detailed technic, although in itself precise, may
be misleading in that it gives one too great a confidence in interpreta-
tion. The answer can only be found in the study of the natural
history of the disease for, after all, the histological picture of malig-
nancy was originally built up on the correlation of microscopic
appearance with the progress of the disease.
The fallacies of the determination of the incidence of cancer in
"chronic cystic mastitis" as usually presented are twofold. The one
is the assumption that the diagnosis of microscopic cancer is valid and
the outcome therefore predictable, the other that the sampling of
instances of this cystic disease is a fair one and therefore that the
incidence of cancer is high. Numerous writers have presented sta-
tistics to this effect. The data presented by Semb26 may be taken
as an example. He divides the disease we are discussing into two
groups, "fibroadenomatosis simplex" (microcystica) and "fibroadeno-
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matosis cystica," the distinction being that in the latter, the cysts are
visible to the naked eye. This last group comprised therefore all
those breasts in which a definite localized tumor was palpable. Of
these there were 70 cases investigated, in which there were 9 in-
stances of definite fibroadenomata, and 20 of adenomatous papillo-
mata. In 17 instances "infiltrating growth of epithelium" was
detected, and of these 10 were diagnosed as "incipient carcinoma," or
precancerous lesions, and 7 as fully developed carcinoma. But
apparently the total number of breasts investigated was 400, of
which 70 then had palpable tumors. Of these, 7, or less than 2
per cent, proved to havedefinite carcinoma on histologic examination.
This is about the incidence of carcinoma in the female breast in
general. That these were all found in the palpable group of tumors
is of significance, and one may only conclude that in this group there
may be, if one is completely incapable of making adifferential diag-
nosis, an error of 10 per cent. The data have no weight in showing
that carcinoma originates from "chronic cystic mastitis." Semb
argues from the reverse direction also. That is, he, as many others
have done, studies the incidence of "fibroadenomatosis" in all in-
stances of cancer ofthe breast and arrives at the figure of 77 per cent.
This is approximately the figure given by Geoffrey Keynes for the
incidence of this disease in breasts of corresponding age removed in a
run of 100 necropsies, so that there is then no significance in this
presumed correlation of chronic cystic mastitis with cancer.
It might be said, however, that Semb was mistaken in his
interpretation of what was and what was not carcinoma, and that
the "precancerous lesions" should be so classed. This is a valid
hypothesis, and the only adequate answer is that which the final
outcome may show. There is a great dearth of papers giving
the follow-up results in this disease, in spite of the fact that in the
final analysis, the decision as to whether or not there is a correlation
between "chronic cystic mastitis" and cancer must be made on the
basis of such data.
Fortunately, Bloodgood2 has made such a study over manyyears.
First believing that chronic cystic disease was a precancerous lesion,
he has arrived by stages at the opposite opinion. In 1921, he
reported upon a follow-up of 350 instances of this disease, in which
there had been an incidence of carcinoma of about 2 per cent. In
1929 he studied a second group of 100 cases, of an apparently more
malignant appearing lesion, the diffuse, non-encapsulated adenoma,
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and found no development ofcancer. In 300 instances ofthe "blue-
domed cyst" in which local excision was practised, there was like-
wise no subsequent malignancy. In 1931 he reviewed all his
"border-line" tumors of the breast and found no subsequent cancer,
and in 1934 he goes so far as to state that the comedo-adenoma can
be distinguished from the comedo-carcinoma and is a benign lesion.
Campbell6 has admirably reviewed the literature of this disease
and determined the subsequent course of 233 patients treated by local
excision; of these 9.2 per cent were followed for three or more
years, 60.4 per cent for five or more, and 15.9 per cent for ten or
wpore. Only one of the 233 patients developed carcinoma and that
in a portion of the breast not involved in the excision. Of the 233,
42 were instances of adenocystic disease. Of 57 patients treated by
simple amputation, there was one death from carcinoma in which the
primary tumor was present in the opposite breast, and a second from
what was said to have been carcinoma of the stomach.
This is the type of investigation that should show correlation of
"chronic cystic mastitis" with carcinoma of the breast if it is present.
It is regrettable that more surgeons have not undertaken such a
survey. Nevertheless, it seems to me most probable that this dis-
ease bears no causal or intimately correlative relationship to cancer
of the breast. It is an entity in itself and should be so considered.
On the other hand, one cannot emphasize too strongly the diffi-
culties of a differential diagnosis in a situation where an error may
be fatal. In the generalized disease without an individual tumor
or definite localization, the chances of error are small, so small
indeed that operative attack is unjustifiable. But where there is a
definite tumor or a localized area of disease, the error of diagnosis
increases to the point where actual examination of the excised tissue
must be obtained. This situation has been studied by Hart"4, who
has followed up a "border-line" group which is supposedly most
malignant in potentiality, that is, the intracystic papillomata. Of
128 cases studied, 104 were benign and 24 malignant, of which 21
were recognized clinically. All of the last group were treated by a
radical mastectomy. Of the benign cases 38 per cent had radical
amputation, 40 per cent conservative amputations, and 22 per cent
local excisions. Sixty-six of these were followed up and all had
remained well, while of the malignant group 10 were followed of
which seven died of cancer. It seems, then, that about 20 per cent
of this so-called "border-line group" are malignant, and that the
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error of clinical diagnosis is less than 3 per cent for the group as a
whole; and about 10 per cent for the malignant component. This
is given not as an illustration of the derivation of papillary growth
from "chronic cystic disease," but of the greater difficulty of diag-
nosis where the lesion is a limited one. It is unsafe to depend upon
apurely clinical diagnosis in such instances, and excision of the tumor
or area in question, often involving a quadrant of the breast, or
when the involvement is greater, a conservative total mastectomy, is
necessary. It is hardly necessary to add that where the clinical
diagnosis of carcinoma is presumptive, the attack should be a radical
mastectomy at once.
The differential diagnosis and treatment of tumors of the breast,
then, rests upon a concept of the so-called "chronic cystic mastitis"
as an aberration of the cyclic changes in that organ associated with
estrus, that is to say, it is a benign lesion. In the generalized form
diagnosis is safe, but in the types limited to certain areas in the
breast or to the single tumor, exploration is necessary because the
differential diagnosis from cancer cannot be made with sufficient
security.
REFERENCES
Berberich, J., and Jaffe, R.: Der Lipoidstoffwechsel der Ovarien mit beson-
derer Beriicksichtigung des Menstruationszyklus nebst Untersuchungen an
Nebennieren und Mamma. Ztschr. f. d. ges. Anat., 2. Abt., Ztschr. f.
Konstitutionslehre, 1924, 10, 1-27.
2 Bloodgood, J. C.: Senile parenchymatous hypertrophy of the female breast.
Surg., Gynec., & Obst., 1906, 3, 721-30.
The pathology of chronic cystic mastitis of the female breast with special con-
sideration of the blue-domed cyst. Arch. Surg., 1921, 3, 445-542.
Benign lesions of female breast for which operation is not indicated. J. Am.
Med. Asso., 1922, 78, 859-63.
Benign tumors of the breast. Encapsulated adenoma. Ann. Surg., 1924, 79,
172-97.
Chronic cystic mastitis of the diffuse, non-encapsulated, cystic adenomatous
type. Ann. Surg., 1929, 90, 886-903.
The blue-domed cyst in chronic cystic mastitis. J. Am. Med. Asso., 1929,
93, 1056-59.
Border-line breast tumors. Ann. Surg., 1931, 93, 235-49.
Comedo carcinoma (or comedo-adenoma) of the female breast. Am. J.
Cancer, 1934, 22, 842-53.
3 Borchardt, M., and Jaffe, R.: Zur Kenntnis der Zystenmamma. Beitr. z.
klin. Chir., 1932, 155, 481-514.CHRONIC CYSTIC MASTITIS 531
4 Brodie, B. C.: Lectures Illustrative of Various Subjects in Pathology and
Surgery. London: Longmans and others, 1846. 411 pp. 8°.
Lecture VII, On Sero-cystic tumors of the female breast. Pages 137-156.
5 Brissaud, E.: Anatomie pathologique de la maladie kystique des mamelles.
Arch. de Physiologie, 3.s., 1884, 3, 98-113.
6 Campbell, 0. J.: Relationship between cystic disease of the breast and car-
cinoma. Arch. Surg., 1934, 28, 1001-56.
7 Cheatle, G. L., and Cutler, M.: Tumours of the breast. London: Edward
Arnold & Co., 1931, 596 pp. 4°.
8 Claiborn, L. N., and Foster, L. C.: Carcinoma of the breast: the results of
radical surgery alone over a ten-year period. [In manuscript.]
9 Cooper, A.: The Anatomy and Diseases of the Breast. Philadelphia: Lea &
Blanchard, 1845.
10 Evans, H. M.: Clinical manifestations of dysfunction of the anterior pituitary.
J. Am. Med. Asso., 1935, 104, 464-72.
11 Geschickter, C. F., Lewis, D., and Hartman, C. G.: Tumors of the breast
related to the cestrin hormone. Am. J. Cancer, 1934, 21, 828-59.
12 Gross, S. W.: A Practical Treatise on Tumors of the Mammary Gland. New
York: Appleton & Co., 1880, 246 pp. 8°.
13 Hammond, J.: On the causes responsible for the developmental progress of
the mammary glands in the rabbit during the later part of pregnancy.
Proc. Roy. Soc., London, 1917, s.B, 89, 534-46.
14 Hart, D.: Intracystic papillomatous tumors of the breast, benign and malignant.
Arch. Surg., 1927, 14, 793-835.
15 Hartman, C.: The cestrous cycle in the opossum. Am. J.-Anat., 1923, 32,
353-421.
16 Ingleby, H.: Relation of fibro-adenoma and chronic mastitis to sexual cycle
changes in the breast. Arch. Path., 1932, 14, 21-41.
17 Keynes, G.: Hunterian lecture (abridged) on chronic mastitis. Lancet, 1923,
ii, 439-45.
18 Ko5nig: Mastitis chronica cystica . . . . Centralbl. f. Chir., 1893, 20, 49-53.
19 Loeb, L., and Hesselberg, C.: The cyclic changes in the mammary gland
under normal and pathological conditions. J. Exper. Med., 1917, 25,
285-321.
20 Moszkowicz, L.: Ueber den monatlichen Zyklus der Brustdriise. Arch. f.
klin. Chir., 1926, 142, 374-418.
21 Paget, J.: Lectures on Surgical Pathology. 4th Ed., London: Longmans,
Green, and Co., 1876, 844 pp. 80.
22 Reclus, P.: La maladie kystique des mamelles. Bull. Soc. Anat. de Paris,
1883, 58, 428-33. La maladie kystique des mamelles. Rev. de Chir.,
1883, 3, 761-75. In symposium on cystic disease of the breast. Ibid.,
1888, 8, 341-42.
23 Rodman, J. S.: Chronic cystic mastitis. Arch. Surg., 1930, 20, 515-20.
Disc., 520-21.
24 Rosenburg, A.: Ueber menstruelle, durch das Corpus luteum bedingte Mam-
maveranderungen. Frankfurt. Ztschr. f. Path., 1922, 27, 466-506.532 YALE JOURNAL OF BIOLOGY AND MEDICLNE
25 Schimmelbusch, C.: Das Cystadenom der Mamma. Arch. f. klin. Chir.,
1892, 44, 117-34.
26 Semb, C.: Fibro-adenomatosis cystica mammae. Acta path. et microbiol.
Scandinavica, 1928, 5, Suppl., 62-67. Disc., 67-70.
27 Sutter, M.: Cyclic changes in the mammary gland of the rat associated with
the oestrous cycle. Anat. Rec., 1921, 21, 591.
28 Turner, C. W.: The Mammary Glands [In] Sex and Internal Secretions.
(Allen) Baltimore: Williams & Wilkins Co., 1932. pp. 544-83.
29 Turner, C. W., and Frank, A. H.: The relation between the estrus-producing
hormone and a corpus luteum extract on the growth of the mammary
gland. Science, 1931, 73, 295-96.
30 Velpeau, A.A.L.M.: A Treatise on the Diseases of the Breast and Mammary
Region. London: Sydenham Society, 1856. 608 pp.
31 Warren, J. C.: Abnormal involution of the mammary gland, with its treatment
by operation. Am. J. Med. Sci., 1907, 133, 521-35.
32 Wieser, C.: Untersuchungen ilber die Miusebrustdrfise und ihre physiolo-
gischen und pathologischen Verinderungen. Arch. f. Gyn., 1934, 156,
534-49.